Release date: 2024-07-09 16:12:45 Recommended: 1113
Dr. Louis, a microbiologist at the World Health Organization (WHO), recently made a technical visit to Lucius Pharmaceuticals in Laos. The purpose of the visit was to learn more about the production process and product quality of Lucius Pharmaceuticals.

During his visit, Dr. Luis conducted an in-depth study of Lucius Pharmaceutical's facilities and operational processes. He expressed his high appreciation for the high standards and professionalism of Lucius Pharmaceuticals. "I am very impressed with the facilities and the professionalism of the staff at Lucius Pharmaceuticals," he said. Their commitment to product quality and sense of responsibility to public health is admirable. ”

In addition, Dr. Luis made some valuable suggestions to Lucius Pharmaceuticals to help them further improve product quality and production efficiency. He stressed the importance of continuous improvement and innovation and encouraged Lucius Pharmaceuticals to continue its efforts in this regard.

Overall, Dr. Luis was very satisfied with the technical visit to Lucius Pharmaceuticals. He looks forward to seeing Lucius Pharmaceuticals continue to maintain its high standards in the future and play an even greater role in the global pharmaceutical industry. The visit not only strengthened the WHO's ties with the Lao pharmaceutical industry, but also set a positive example for other pharmaceutical companies.
Dr. Louis, a microbiologist at the World Health Organization (WHO), recently mad···【more】
Recommended:1114Release date: 2024-07-09
Lung cancer is the most rapidly increasing malignant tumor with the fastest incr···【more】
Recommended:1054Release date: 2024-07-09
Lucius Pharmaceuticals Version of Vibegron Now Available1.Basic Drug Information···【more】
Recommended:420Release date: 2026-08-06
Lucius Pharmaceuticals version of Ibrutinib is now availableIn a randomized cont···【more】
Recommended:475Release date: 2026-08-03
Alectinib Has Been Launched in LaosAlectinib is an oral targeted therapeutic dru···【more】
Recommended:333Release date: 2026-07-30
Lucius Pharmaceuticals Quizartinib (Quizartinib) Has Been Launched(1) Quizartini···【more】
Recommended:347Release date: 2026-07-29
Lucius version of Dacomitinib is now availableCutaneous adverse reactions and ma···【more】
Recommended:375Release date: 2026-07-21
Lao PDR: Filgotinib Has Been LaunchedBefore initiating filgotinib treatment, str···【more】
Recommended:349Release date: 2026-07-13
Recently, Lao Lucius Pharmaceutical (Lucius Pharmaceuticals) issued a solemn sta···【more】
Recommended:346Release date: 2026-10-10
In recent years, leveraging the World Trade Organization (WTO) patent waiver for···【more】
Recommended:619Release date: 2026-08-05
How Can Chinese Patients Access Generic Drugs from Laos?In recent years, generic···【more】
Recommended:604Release date: 2026-08-04
Leveraging the WTO patent waiver for least-developed countries (extended to 2033···【more】
Recommended:622Release date: 2026-07-31
Lucius Pharmaceutical is a modern pharmaceutical enterprise headquartered in Vie···【more】
Recommended:431Release date: 2026-07-28
Lucius Pharmaceuticals Relocates from India to Laos: A Five-Year Development Jou···【more】
Recommended:679Release date: 2026-07-24